Drug
Supplemental oxygen therapy
Supplemental oxygen therapy is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
100%(1 trials)
Phase Distribution
Ph phase_3
1
25%
Ph phase_4
1
25%
Ph not_applicable
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(1)
Other(1)
Detailed Status
Recruiting1
unknown1
Completed1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (25.0%)
Phase 41 (25.0%)
N/A2 (50.0%)
Trials by Status
recruiting125%
unknown125%
completed125%
not_yet_recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
not_yet_recruitingphase_4
Effect of Supplemental Oxygen Therapy on Neurocognitive Performance in Healthy Highlanders
NCT07651917
recruitingnot_applicable
Supplemental High Flow Oxygen to Reduce Infections in Obese Gynecological Cancer Patients
NCT06780813
unknownnot_applicable
HA Residents With PVD, Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) With and Without Supplemental Oxygen Therapy (SOT)
NCT06084559
completedphase_3
Long-term Oxygen Treatment Trial
NCT00692198
Clinical Trials (4)
Showing 4 of 4 trials
NCT07651917Phase 4
Effect of Supplemental Oxygen Therapy on Neurocognitive Performance in Healthy Highlanders
NCT06780813Not Applicable
Supplemental High Flow Oxygen to Reduce Infections in Obese Gynecological Cancer Patients
NCT06084559Not Applicable
HA Residents With PVD, Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) With and Without Supplemental Oxygen Therapy (SOT)
NCT00692198Phase 3
Long-term Oxygen Treatment Trial
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4